Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells

Oncology Reports

Volumn 35, Issue 6, 2016, Pages 3395-3402

  Jin, Shu Guang ^a   Ryu, Hyang Hwa ^b   Li, Song Yuan ^b   Li, Chun Hao ^b   Lim, Sa Hoe ^b   Jang, Woo Youl ^b   Jung, Shin ^b  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Invasion; Malignant glioma; Migration; Nogo A; U87mg cell line

Indexed keywords

COFILIN; COMPLEMENTARY DNA; MATRIGEL; PROTEIN NOGO A; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ACTIN; ACTIN DEPOLYMERIZING FACTOR; PROTEIN NOGO; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; DNA VECTOR; DOWN REGULATION; GENE CONSTRUCT; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; NEURILEMOMA; OLIGODENDROGLIOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BRAIN TUMOR; CELL MOTION; GLIOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ACTIN DEPOLYMERIZING FACTORS; ACTINS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; NOGO PROTEINS; RHO GTP-BINDING PROTEINS;

EID: 84964843835     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4737     Document Type: Article

References (38)

1. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001.
2. Guo L, Qiu Y, Ge J and Zhou D: Glioblastoma multiforme with subcutaneous metastases, case report and literature review. J Korean Neurosurg Soc 52: 484-487, 2012.
3. Oertle T, Klinger M, Stuermer CA and Schwab ME: A reticular rhapsody: Phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J 17: 1238-1247, 2003.
4. GrandPré T, Li S and Strittmatter SM: Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417: 547-551, 2002.
5. Huber AB, Weinmann O, Brösamle C, Oertle T and Schwab ME: Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22: 3553-3567, 2002.
6. Hunt D, Coffin RS, Prinjha RK, Campbell G and Anderson PN: Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 24: 1083-1102, 2003.
7. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA and Strittmatter SM: Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 22: 5505-5515, 2002.
8. Josephson A, Widenfalk J, Widmer HW, Olson L and Spenger C: NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 169: 319-328, 2001.
9. Niederöst B, Oertle T, Fritsche J, McKinney RA and Bandtlow CE: Nogo-A and myelin- Associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22: 10368-10376, 2002.
10. Boureux A, Vignal E, Faure S and Fort P: Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol 24: 203-216, 2007.
11. Kuhlmann T, Gutenberg A, Schulten HJ, Paulus W, Rohde V and Bruck W: Nogo- A expression in glial CNS tumors: A tool to differentiate between oligodendrogliomas and other gliomas? Am J Surg Pathol 32: 1444-1453, 2008.
12. Xiong NX, Zhao HY, Zhang FC and He ZQ: Negative correlation of Nogo-A with the malignancy of oligodendroglial tumor. Neurosci Bull 23: 41-45, 2007.
13. Jung TY, Jung S, Lee KH, Cao VT, Jin SG, Moon KS, Kim IY, Kang SS, Kim HS and Lee MC: Nogo-A expression in oligodendroglial tumors. Neuropathology 31: 11-19, 2011.
14. Schwab ME: Myelin- Associated inhibitors of neurite growth and regeneration in the CNS. Trends Neurosci 13: 452-456, 1990.
15. Teng FY and Tang BL: No go for brain tumors? J Mol Neurosci 25: 1-6, 2005.
16. Walker JM: The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol 32: 5-8, 1994.
17. Giese A and Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39: 235-252, 1996.
18. van de Velde HJ, Roebroek AJ, Senden NH, Ramaekers FC and Van de Ven WJ: NSP-encoded reticulons, neuroendocrine proteins of a novel gene family associated with membranes of the endoplasmic reticulum. J Cell Sci 107: 2403-2416, 1994.
19. Buss A, Sellhaus B, Wolmsley A, Noth J, Schwab ME and Brook GA: Expression pattern of NOGO-A protein in the human nervous system. Acta Neuropathol 110: 113-119, 2005.
20. Mingorance-Le Meur A, Zheng B, Soriano E and del Río JA: Involvement of the myelin- Associated inhibitor Nogo-A in early cortical development and neuronal maturation. Cereb Cortex 17: 2375-2386, 2007.
21. Su Z, Cao L, Zhu Y, Liu X, Huang Z, Huang A and He C: Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J Cell Sci 120: 1877-1887, 2007.
22. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT and Horwitz AR: Cell migration: Integrating signals from front to back. Science 302: 1704-1709, 2003.
23. Pollard TD and Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003.
24. Raftopoulou M and Hall A: Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32, 2004.
25. Yamazaki D, Kurisu S and Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386, 2005.
26. Glotzer M: The molecular requirements for cytokinesis. Science 307: 1735-1739, 2005.
27. Ridley AJ: Rho GTPases and cell migration. J Cell Sci 114: 2713-2722, 2001.
28. Chrzanowska-Wodnicka M and Burridge K: Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133: 1403-1415, 1996.
29. Fritz G, Just I and Kaina B: Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682-687, 1999.
30. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T and Konishi I: Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83: 861-870, 2003.
31. Kamai T, Arai K, Tsujii T, Honda M and Yoshida K: Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 87: 227-231, 2001.
32. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y and Oshima H: Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641, 2003.
33. Liu N, Bi F, Pan Y, Sun L, Xue Y, Shi Y, Yao X, Zheng Y and Fan D: Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 10: 6239-6247, 2004.
34. Yan B, Chour HH, Peh BK, Lim C and Salto-Tellez M: RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci Lett 407: 124-126, 2006.
35. Bernard O: Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 39: 1071-1076, 2007.
36. Endo M, Ohashi K, Sasaki Y, Goshima Y, Niwa R, Uemura T and Mizuno K: Control of growth cone motility and morphology by LIM kinase and Slingshot via phosphorylation and dephosphorylation of cofilin. J Neurosci 23: 2527-2537, 2003.
37. Endo M, Ohashi K and Mizuno K: LIM kinase and slingshot are critical for neurite extension. J Biol Chem 282: 13692-13702, 2007.
38. Ridley AJ: Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16: 522-529, 2006.